{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04520217",
            "orgStudyIdInfo": {
                "id": "06919"
            },
            "organization": {
                "fullName": "Wright State University",
                "class": "OTHER"
            },
            "briefTitle": "Testing Use of Topical Imipramine in Reducing Ultraviolet B Induced Microvesicle Particle Release in Photosensitive Subjects",
            "officialTitle": "Pilot Studies Testing Use of Topical Imipramine in Reducing Ultraviolet B Induced Microvesicle Particle Release in Photosensitive Subjects",
            "therapeuticArea": [
                "Other"
            ],
            "study": "testing-use-of-topical-imipramine-in-reducing-ultraviolet-b-induced-microvesicle-particle-release-in-photosensitive-subjects"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-06-06",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-08-17",
            "studyFirstSubmitQcDate": "2020-08-17",
            "studyFirstPostDateStruct": {
                "date": "2020-08-20",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-01",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-04",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Wright State University",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is three-fold. First, researchers will assess whether subjects who have clinically abnormal reactions to sunlight (photosensitivity) have increased levels of microvesicle particles (MVP) following ultraviolet B (UVB) treatment to localized area of skin. Second, researchers will assess if topical application of the medicine imipramine will block UVB-induced MVP release. Third, researchers will assess if the topical cream will block UVB-induced increased erythema reactions (reddening of the skin)."
        },
        "conditionsModule": {
            "conditions": [
                "Photosensitivity",
                "Microvesicle Particle"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "PREVENTION",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 40,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "4% Imipramine Cream on UVB-Treated Areas",
                    "type": "EXPERIMENTAL",
                    "description": "* 2g of 4% imipramine cream will be applied to the UVB-treated areas on volar forearm and back.\n* 2g of base cream will be applied to the UVB-treated areas on volar forearm and back.\n* No cream will be applied to a UVB-treated area on the back",
                    "interventionNames": [
                        "Drug: 4% Imipramine Cream",
                        "Drug: Base Cream"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "4% Imipramine Cream",
                    "description": "4% Imipramine Cream",
                    "armGroupLabels": [
                        "4% Imipramine Cream on UVB-Treated Areas"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Base Cream",
                    "description": "Base Cream",
                    "armGroupLabels": [
                        "4% Imipramine Cream on UVB-Treated Areas"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in microvesicle particle levels from baseline in clinically photosensitive subjects",
                    "description": "This will be measured in skin biopsies obtained at 4 hours following ultraviolet B radiation fluence of 1000 J/m2.",
                    "timeFrame": "4 Hours"
                },
                {
                    "measure": "Change in microvesicle particle levels from baseline post topical imipramine application",
                    "description": "This will be measured in skin biopsies with topical imipramine applied. Biopsies are obtained at 4 hours following ultraviolet B radiation fluence of 1000 J/m2.",
                    "timeFrame": "4 Hours"
                },
                {
                    "measure": "Change in skin erythema from baseline on topical imipramine treated skin",
                    "description": "This will be measured with a mexameter at 4 hours.",
                    "timeFrame": "4 Hours"
                },
                {
                    "measure": "Change in skin erythema from baseline on topical imipramine treated skin",
                    "description": "This will be measured with a mexameter at 24 hours.",
                    "timeFrame": "24 Hours"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Female and Male adult subjects age 18 to 50\n* Must be able to give informed consent\n* Have access to stable transportation\n* All skin types on Fitzpatrick Scale (Type I-VI)\n* Self-Identified photosensitivity\n* Able to provide medical history and list of medications-control subjects will not be allowed to be taking a medication that is known to be photosensitizer.\n\nExclusion Criteria:\n\n* Underlying diseases that could affect wound healing (e.g., uncontrolled diabetes mellitus)\n* Taking medications that are known photosensitizers (e.g., doxycycline) or anti-inflammatories (e.g., NSAIDS \\[except for low-dose aspirin\\] or steroids)\n* Utilizing imipramine or any other tricyclic antidepressant (oral or cream)\n* Utilizing topical anti-inflammatory or systemic agents (e.g., prednisone)\n* Large tattoos in the designated testing areas\n* Tanning bed use within last 3 months\n* Photodynamic Therapy or UVB treatments in past 3 months\n* Female Subjects: pregnant or nursing\n* History of abnormal scarring (i.e., keloids)",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "50 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Manager Clinical Research Operations",
                    "role": "CONTACT",
                    "phone": "937-245-7500",
                    "email": "pturesearch@wrightstatephysicians.org"
                },
                {
                    "name": "Regulatory Specialist",
                    "role": "CONTACT",
                    "phone": "937-245-7500",
                    "email": "pturesearch@wrightstatephysicians.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Jeffrey B Travers, MD, PhD",
                    "affiliation": "Wright State University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Wright State Physicians",
                    "status": "RECRUITING",
                    "city": "Fairborn",
                    "state": "Ohio",
                    "zip": "45324",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.82089,
                        "lon": -84.01938
                    }
                }
            ]
        }
    },
    "documentSection": {
        "largeDocumentModule": {
            "largeDocs": [
                {
                    "typeAbbrev": "ICF",
                    "hasProtocol": false,
                    "hasSap": false,
                    "hasIcf": true,
                    "label": "Informed Consent Form",
                    "date": "2022-04-11",
                    "uploadDate": "2023-02-20T17:16",
                    "filename": "ICF_000.pdf",
                    "size": 297633
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007099",
                    "term": "Imipramine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000929",
                    "term": "Antidepressive Agents, Tricyclic"
                },
                {
                    "id": "D000000928",
                    "term": "Antidepressive Agents"
                },
                {
                    "id": "D000011619",
                    "term": "Psychotropic Drugs"
                },
                {
                    "id": "D000018759",
                    "term": "Adrenergic Uptake Inhibitors"
                },
                {
                    "id": "D000014179",
                    "term": "Neurotransmitter Uptake Inhibitors"
                },
                {
                    "id": "D000049990",
                    "term": "Membrane Transport Modulators"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000018663",
                    "term": "Adrenergic Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10147",
                    "name": "Imipramine",
                    "asFound": "Epicondylitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4247",
                    "name": "Antidepressive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4248",
                    "name": "Antidepressive Agents, Tricyclic",
                    "relevance": "LOW"
                },
                {
                    "id": "M14474",
                    "name": "Psychotropic Drugs",
                    "relevance": "LOW"
                },
                {
                    "id": "M20746",
                    "name": "Adrenergic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "PsychDr",
                    "name": "Psychotropic Drugs"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}